1.Preliminary Study on Reversal of Sorafenib Resistance of Hepatocellular Carcinoma Cells by Huaier Granule
Zheng-Guang1 ZHANG ; Bing1 LIU ; Wei-Feng1 LIANG ; Cun-Si2 SHEN
Journal of Nanjing University of Traditional Chinese Medicine 2020;36(1):83-87
OBJECTIVE To investigate the effect and related mechanism of Huaier granule on Sorafenib-resistant hepatocellular carcinoma cells BEL-7402/S. METHODS The proliferation-toxicity effect of Huaier granule on BEL-7402/S cells and the reversal multiple of drug resistance to Sorafenib were measured by CCK-8 assays. The effects of Huaier granule on the mRNA and protein levels of hypoxia inducible factor-lα(H7F-lα) and vascular endothelial growth factor (VEGF) in BEL-7402/S cells were detected by qPCR and Western blot, respectively. RESULTS Huaier granule inhibited the activities of BEL-7402/S cells, and partially reversed the resistance of BEL-7402/S cells to Sorafenib at the dose of no significant cytotoxicity, and the reversal multiple of drug resistance was 2.08;the results of qPCR showed that Huaier granule may down-regulate the mRNA level of HIF-lαin BEL-7402/S cells, but had no significant effect on the mRNA level of VEGF. The results of Western blot showed that Huaier granule may down-regulate the protein levels of HIF-lαand VEGF in BEL-7402/S cells. CONCLUSION Huaier granule may partially reverse the drug resistance of BEL-7402/S cells to Sorafenib, and its mechanism may be related to the decrease of the expression of H7F-lαand VEGF.
2.The mechanism of BRCC3/NLRP3 in promoting the transformation of endometriosis to endometriosis-associated ovarian carcinoma
LIU Yu1 ; WU Qiongwei1 ; ZHANG Wenying1 ; WANG Chunchun1 ; HUANG Yuhua1 ; LI Bing1 ; MA Chengbin1 ; YANG Yu2
Chinese Journal of Cancer Biotherapy 2023;30(1):35-41
[摘 要] 目的:探讨NOD样受体蛋白3(NLRP3)炎症小体的活化在子宫内膜异位症(EMT)进展为EMT相关性卵巢癌(EAOC)过程中的作用及其机制。方法:选取2018年4月至2019年6月上海市长宁区幼保健院收治的EAOC、EMT、正常子宫内膜(CON组)组织标本各15例及患者的临床资料,利用免疫组织化学染色法、WB法检测EAOC、EMT和CON组织中NLRP3、caspase-1和IL-1β及含BRCA1/BRCA2的复杂亚基3(BRCC3)的表达水平。构建过表达BRCC3质粒和si-NLRP3质粒并转染EMT细胞CRL-7566,通过WB法检测转染后细胞中BRCC3蛋白的表达水平,利用MTT法、流式细胞术及Transwell实验分别检测转染后细胞增殖、凋亡、迁移与侵袭能力的变化。对过表达BRCC3组细胞进行干扰NLRP3实验,通过WB法检测干扰后BRCC3和NLRP3蛋白的表达水平,检测干扰后细胞增殖、凋亡、迁移与侵袭能力的变化。结果:EAOC和EMT组织中NLRP3、caspase-1、IL-1β和BRCC3的表达水平较CON组均呈明显升高(均P<0.01),且EAOC组织中NLRP3与BRCC3的表达呈正相关(r=0.65,P<0.01)。在CRL-7566细胞中过表达BRCC3显著促进细胞的增殖、迁移和侵袭并抑制细胞凋亡(均P<0.01),敲减NLRP3则抑制CRL-7566细胞的上述表型(均P<0.01),过表达BRCC3增强NLRP3的表达水平(P<0.01),而干扰BRCC3则抑制NLRP3表达(P<0.01);干扰NLRP3可以部分逆转BRCC3对细胞凋亡的抑制作用(P<0.01)、对细胞迁移(P<0.05)和侵袭(P<0.01)的促进作用。结论:EAOC和EMT组织中NLRP3和BRCC3均呈高表达,过表达BRCC3可促进CRL-7566细胞的增殖、迁移和侵袭并抑制细胞凋亡,与EMT向EAOC转化有关,BRCC3/NLRP3是潜在的EAOC炎癌转化预测标志物及治疗靶点。